Michael J Kelso
Dr Kelso graduated in 1996 from the University of Wollongong with a B. Medicinal Chemistry and received his PhD in 2002 from the Institute for Molecular Bioscience (University of Queensland). After a one year postdoc with Professor Claudio Palomo (Universidad del Pais Vasco, Spain) studying asymmetric catalysis he moved to The Scripps Research Institute (CA, USA) to study medicinal chemistry as a CJ Martin Postdoctoral Fellow under Professor Dale Boger. Upon returning to Australia in 2006 he completed his CJ Martin Fellowship under Professor John Bremner at the University of Wollongong before being appointed to the faculty in 2008. His research focuses on dual- and multi-action antimicrobial and anti-cancer hybrid drugs and prodrugs.
Abstracts this author is presenting:
